Personal information

No personal information available

Activities

Collapse all

Works (28)

ENPP1/CD203a-targeting heavy-chain antibody reveals cell-specific expression on human immune cells

Cellular and Molecular Life Sciences
2024-12-18 | Journal article
DOI: 10.1007/s00018-024-05539-y
Contributors: Hannah Lorenz; Stephan Menzel; Nataliia Roshchyna; Birte Albrecht; Anna Josephine Gebhardt; Enja Schneider; Friedrich Haag; Björn Rissiek; Ralf Oheim; Friedrich Koch-Nolte et al.
Source: check_circle
Crossref

Evaluation of nanobody-based biologics targeting purinergic checkpoints in tumor models <i>in vivo</i>.

Frontiers in immunology
2022-10 | Journal article
DOI: 10.3389/fimmu.2022.1012534
PMID: 36341324
PMC: PMC9626963
Contributors: Demeules M; Scarpitta A; Hardet R; Gondé H; Abad C; Blandin M; Menzel S; Duan Y; Rissiek B; Magnus T et al.
Source: Self-asserted source
Stephan Menzel via Europe PubMed Central

Natural killer cell-mediated ADCC in SARS-CoV-2-infected individuals and vaccine recipients.

European journal of immunology
2022-04 | Journal article
DOI: 10.1002/eji.202149470
PMID: 35416291
PMC: PMC9087393
Contributors: Hagemann K; Riecken K; Jung JM; Hildebrandt H; Menzel S; Bunders MJ; Fehse B; Koch-Nolte F; Heinrich F; Peine S et al.
Source: Self-asserted source
Stephan Menzel via Europe PubMed Central

Development of Antibody and Nanobody Tools for P2X7.

Methods in molecular biology (Clifton, N.J.)
2022-01 | Journal article
DOI: 10.1007/978-1-0716-2384-8_6
PMID: 35776322
Contributors: Stähler T; Danquah W; Demeules M; Gondé H; Hardet R; Haag F; Adriouch S; Koch-Nolte F; Menzel S
Source: Self-asserted source
Stephan Menzel via Europe PubMed Central

TRPM2 Is Not Required for T-Cell Activation and Differentiation.

Frontiers in immunology
2022-01 | Journal article
DOI: 10.3389/fimmu.2021.778916
PMID: 35095852
PMC: PMC8795911
Contributors: Lory NC; Nawrocki M; Corazza M; Schmid J; Schumacher V; Bedke T; Menzel S; Koch-Nolte F; Guse AH; Huber S et al.
Source: Self-asserted source
Stephan Menzel via Europe PubMed Central

Combined Blockade of TIGIT and CD39 or A2AR Enhances NK-92 Cell-Mediated Cytotoxicity in AML.

International journal of molecular sciences
2021-11 | Journal article
DOI: 10.3390/ijms222312919
PMID: 34884723
PMC: PMC8657570
Contributors: Brauneck F; Seubert E; Wellbrock J; Schulze Zur Wiesch J; Duan Y; Magnus T; Bokemeyer C; Koch-Nolte F; Menzel S; Fiedler W
Source: Self-asserted source
Stephan Menzel via Europe PubMed Central

Mouse CD38-Specific Heavy Chain Antibodies Inhibit CD38 GDPR-Cyclase Activity and Mediate Cytotoxicity Against Tumor Cells.

Frontiers in immunology
2021-09 | Journal article
DOI: 10.3389/fimmu.2021.703574
PMID: 34539634
PMC: PMC8446682
Contributors: Baum N; Eggers M; Koenigsdorf J; Menzel S; Hambach J; Staehler T; Fliegert R; Kulow F; Adam G; Haag F et al.
Source: Self-asserted source
Stephan Menzel via Europe PubMed Central

Identification of the Mouse T Cell ADP-Ribosylome Uncovers ARTC2.2 Mediated Regulation of CD73 by ADP-Ribosylation.

Frontiers in immunology
2021-08 | Journal article
DOI: 10.3389/fimmu.2021.703719
PMID: 34504490
PMC: PMC8421852
Contributors: Leutert M; Duan Y; Winzer R; Menzel S; Tolosa E; Magnus T; Hottiger MO; Koch-Nolte F; Rissiek B
Source: Self-asserted source
Stephan Menzel via Europe PubMed Central

A simple, sensitive, and low-cost FACS assay for detecting antibodies against the native SARS-CoV-2 spike protein.

Immunity, inflammation and disease
2021-05 | Journal article
DOI: 10.1002/iid3.446
PMID: 33979020
PMC: PMC8239943
Contributors: Hambach J; Stähler T; Eden T; Wendt D; Tode N; Haag F; Tolosa E; Altfeld M; Fathi A; Dahlke C et al.
Source: Self-asserted source
Stephan Menzel via Europe PubMed Central

ADP-Ribosylation Regulates the Signaling Function of IFN-γ.

Frontiers in immunology
2021-03 | Journal article
DOI: 10.3389/fimmu.2021.642545
PMID: 33763084
PMC: PMC7983947
Contributors: Menzel S; Koudelka T; Rissiek B; Haag F; Meyer-Schwesinger C; Tholey A; Koch-Nolte F
Source: Self-asserted source
Stephan Menzel via Europe PubMed Central

Daratumumab and Nanobody-Based Heavy Chain Antibodies Inhibit the ADPR Cyclase but not the NAD+ Hydrolase Activity of CD38-Expressing Multiple Myeloma Cells.

Cancers
2020-12 | Journal article
DOI: 10.3390/cancers13010076
PMID: 33396591
PMC: PMC7795599
Contributors: Baum N; Fliegert R; Bauche A; Hambach J; Menzel S; Haag F; Bannas P; Koch-Nolte F
Source: Self-asserted source
Stephan Menzel via Europe PubMed Central

Nanobody-based CD38-specific heavy chain antibodies induce killing of multiple myeloma and other hematological malignancies.

Theranostics
2020-02 | Journal article
DOI: 10.7150/thno.38533
PMID: 32194826
PMC: PMC7052896
Contributors: Schriewer L; Schütze K; Petry K; Hambach J; Fumey W; Koenigsdorf J; Baum N; Menzel S; Rissiek B; Riecken K et al.
Source: Self-asserted source
Stephan Menzel via Europe PubMed Central

Astrocytes and Microglia Are Resistant to NAD+-Mediated Cell Death Along the ARTC2/P2X7 Axis.

Frontiers in molecular neuroscience
2020-01 | Journal article
DOI: 10.3389/fnmol.2019.00330
PMID: 32009900
PMC: PMC6971201
Contributors: Rissiek B; Stabernack J; Cordes M; Duan Y; Behr S; Menzel S; Magnus T; Koch-Nolte F
Source: Self-asserted source
Stephan Menzel via Europe PubMed Central

Clinical Relevance of Domain-Specific Phospholipase A<sub>2</sub> Receptor 1 Antibody Levels in Patients with Membranous Nephropathy.

Journal of the American Society of Nephrology : JASN
2019-12 | Journal article
DOI: 10.1681/asn.2019030273
PMID: 31843985
PMC: PMC6935013
Contributors: Reinhard L; Zahner G; Menzel S; Koch-Nolte F; Stahl RAK; Hoxha E
Source: Self-asserted source
Stephan Menzel via Europe PubMed Central

Generation and Characterization of Specific Monoclonal Antibodies and Nanobodies Directed Against the ATP-Gated Channel P2X4.

Frontiers in cellular neuroscience
2019-11 | Journal article
DOI: 10.3389/fncel.2019.00498
PMID: 31798414
PMC: PMC6861843
Contributors: Bergmann P; Garcia de Paco E; Rissiek B; Menzel S; Dubberke G; Hua J; Rassendren F; Ulmann L; Koch-Nolte F
Source: Self-asserted source
Stephan Menzel via Europe PubMed Central

Novel biologics targeting the P2X7 ion channel.

Current opinion in pharmacology
2019-04 | Journal article
DOI: 10.1016/j.coph.2019.03.001
PMID: 30986625
Contributors: Koch-Nolte F; Eichhoff A; Pinto-Espinoza C; Schwarz N; Schäfer T; Menzel S; Haag F; Demeules M; Gondé H; Adriouch S
Source: Self-asserted source
Stephan Menzel via Europe PubMed Central

CD38-Specific Biparatopic Heavy Chain Antibodies Display Potent Complement-Dependent Cytotoxicity Against Multiple Myeloma Cells.

Frontiers in immunology
2018-11 | Journal article
DOI: 10.3389/fimmu.2018.02553
PMID: 30524421
PMC: PMC6262402
Contributors: Schütze K; Petry K; Hambach J; Schuster N; Fumey W; Schriewer L; Röckendorf J; Menzel S; Albrecht B; Haag F et al.
Source: Self-asserted source
Stephan Menzel via Europe PubMed Central

Proteomic Characterization of the Heart and Skeletal Muscle Reveals Widespread Arginine ADP-Ribosylation by the ARTC1 Ectoenzyme.

Cell reports
2018-08 | Journal article
DOI: 10.1016/j.celrep.2018.07.048
PMID: 30110646
Contributors: Leutert M; Menzel S; Braren R; Rissiek B; Hopp AK; Nowak K; Bisceglie L; Gehrig P; Li H; Zolkiewska A et al.
Source: Self-asserted source
Stephan Menzel via Europe PubMed Central

Nanobody-Based Biologics for Modulating Purinergic Signaling in Inflammation and Immunity.

Frontiers in pharmacology
2018-03 | Journal article
DOI: 10.3389/fphar.2018.00266
PMID: 29636685
PMC: PMC5880931
Contributors: Menzel S; Schwarz N; Haag F; Koch-Nolte F
Source: Self-asserted source
Stephan Menzel via Europe PubMed Central

A cDNA Immunization Strategy to Generate Nanobodies against Membrane Proteins in Native Conformation.

Frontiers in immunology
2018-01 | Journal article
DOI: 10.3389/fimmu.2017.01989
PMID: 29410663
PMC: PMC5787055
Contributors: Eden T; Menzel S; Wesolowski J; Bergmann P; Nissen M; Dubberke G; Seyfried F; Albrecht B; Haag F; Koch-Nolte F
Source: Self-asserted source
Stephan Menzel via Europe PubMed Central

Monitoring Expression and Enzyme Activity of Ecto-ARTCs.

Methods in molecular biology (Clifton, N.J.)
2018-01 | Journal article
DOI: 10.1007/978-1-4939-8588-3_11
PMID: 30097867
Contributors: Menzel S; Adriouch S; Bannas P; Haag F; Koch-Nolte F
Source: Self-asserted source
Stephan Menzel via Europe PubMed Central

Ecto-ADP-ribosyltransferase ARTC2.1 functionally modulates FcγR1 and FcγR2B on murine microglia.

Scientific reports
2017-11 | Journal article
DOI: 10.1038/s41598-017-16613-w
PMID: 29184112
PMC: PMC5705771
Contributors: Rissiek B; Menzel S; Leutert M; Cordes M; Behr S; Jank L; Ludewig P; Gelderblom M; Rissiek A; Adriouch S et al.
Source: Self-asserted source
Stephan Menzel via Europe PubMed Central

Nanobodies effectively modulate the enzymatic activity of CD38 and allow specific imaging of CD38+ tumors in mouse models in vivo.

Scientific reports
2017-10 | Journal article
DOI: 10.1038/s41598-017-14112-6
PMID: 29084989
PMC: PMC5662768
Contributors: Fumey W; Koenigsdorf J; Kunick V; Menzel S; Schütze K; Unger M; Schriewer L; Haag F; Adam G; Oberle A et al.
Source: Self-asserted source
Stephan Menzel via Europe PubMed Central

Identification of the ectoenzyme CD38 as a marker of committed preadipocytes.

International journal of obesity (2005)
2017-06 | Journal article
DOI: 10.1038/ijo.2017.140
PMID: 28611394
Contributors: Carrière A; Jeanson Y; Côté JA; Dromard C; Galinier A; Menzel S; Barreau C; Dupuis-Coronas S; Arnaud E; Girousse A et al.
Source: Self-asserted source
Stephan Menzel via Europe PubMed Central

Nucleotide-Induced Membrane-Proximal Proteolysis Controls the Substrate Specificity of T Cell Ecto-ADP-Ribosyltransferase ARTC2.2.

Journal of immunology (Baltimore, Md. : 1950)
2015-07 | Journal article
DOI: 10.4049/jimmunol.1401677
PMID: 26209623
Contributors: Menzel S; Rissiek B; Bannas P; Jakoby T; Miksiewicz M; Schwarz N; Nissen M; Haag F; Tholey A; Koch-Nolte F
Source: Self-asserted source
Stephan Menzel via Europe PubMed Central

Selection of nanobodies that block the enzymatic and cytotoxic activities of the binary Clostridium difficile toxin CDT.

Scientific reports
2015-01 | Journal article
DOI: 10.1038/srep07850
PMID: 25597743
PMC: PMC4297958
Contributors: Unger M; Eichhoff AM; Schumacher L; Strysio M; Menzel S; Schwan C; Alzogaray V; Zylberman V; Seman M; Brandner J et al.
Source: Self-asserted source
Stephan Menzel via Europe PubMed Central

ARTC1-mediated ADP-ribosylation of GRP78/BiP: a new player in endoplasmic-reticulum stress responses.

Cellular and molecular life sciences : CMLS
2014-10 | Journal article
DOI: 10.1007/s00018-014-1745-6
PMID: 25292337
Contributors: Fabrizio G; Di Paola S; Stilla A; Giannotta M; Ruggiero C; Menzel S; Koch-Nolte F; Sallese M; Di Girolamo M
Source: Self-asserted source
Stephan Menzel via Europe PubMed Central

The art of blocking ADP-ribosyltransferases (ARTs): nanobodies as experimental and therapeutic tools to block mammalian and toxin ARTs.

The FEBS journal
2013-06 | Journal article
DOI: 10.1111/febs.12313
PMID: 23627412
Contributors: Menzel S; Rissiek B; Haag F; Goldbaum FA; Koch-Nolte F
Source: Self-asserted source
Stephan Menzel via Europe PubMed Central
How many people are using ORCID?